These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Antihypertensive effectiveness of very low doses of hydrochlorothiazide: results of the PHICOG Trial. Maroko PR; McDevitt JT; Fox MJ; Silber SA; Young MD; Beg M; Rockhold FW; Free SM; Herron JR; Gray JM Clin Ther; 1989; 11(1):94-119. PubMed ID: 2655909 [TBL] [Abstract][Full Text] [Related]
43. Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Verapamil versus Diuretic (VERDI) Trial Research Group. Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S BMJ; 1989 Oct; 299(6704):881-6. PubMed ID: 2510877 [TBL] [Abstract][Full Text] [Related]
44. Potassium-sparing effects of triamterene in the treatment of hypertension. Spiekerman RE; Berge KG; Thurber DL; Gedge SW; McGuckin WF Circulation; 1966 Sep; 34(3):524-31. PubMed ID: 5332122 [No Abstract] [Full Text] [Related]
46. Changes in the ratio of plasma to intersitiial fluid volume during long-term antihypertensive therapy. Leth A; Ibsen H J Lab Clin Med; 1976 May; 87(5):781-91. PubMed ID: 1270888 [TBL] [Abstract][Full Text] [Related]
47. Efficacy of an antihypertensive agent. Comparison of methyldopa and hydrochlorothiazide in combination and singly. McMahon FG JAMA; 1975 Jan; 231(2):155-8. PubMed ID: 1088916 [TBL] [Abstract][Full Text] [Related]
48. Double blind evaluation of indoramin and methyldopa in thiazide treated hypertensive patients. Yajnik VH; Patel SC Indian Heart J; 1978; 30(1):51-6. PubMed ID: 359454 [No Abstract] [Full Text] [Related]
50. Renal failure with potassium-sparing diuretics. Lynn KL; Bailey RR; Swainson CP; Sainsbury R; Low WI N Z Med J; 1985 Aug; 98(784):629-33. PubMed ID: 3861973 [TBL] [Abstract][Full Text] [Related]
51. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [TBL] [Abstract][Full Text] [Related]
52. Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. Siegel D; Hulley SB; Black DM; Cheitlin MD; Sebastian A; Seeley DG; Hearst N; Fine R JAMA; 1992 Feb; 267(8):1083-9. PubMed ID: 1735925 [TBL] [Abstract][Full Text] [Related]
53. [Comparative clinical experimental studies with pure alpha-methyldopa and in combination with hydrochlorothiazide]. Fiegel G; Bargheer R; Heindorf M Wien Klin Wochenschr; 1965 Jun; 77(25):470-2. PubMed ID: 5319350 [No Abstract] [Full Text] [Related]
54. Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination. Moncloa F; Hwang IK; Muccilli AC Clin Ther; 1980; 3(3):168-75. PubMed ID: 7006811 [TBL] [Abstract][Full Text] [Related]
55. Comparative efficacy and bioequivalence of a brand-name and a generic triamterene-hydrochlorothiazide combination product. Sharoky M; Perkal M; Tabatznik B; Cane RC; Costello K; Goodwin P Clin Pharm; 1989 Jul; 8(7):496-500. PubMed ID: 2752698 [TBL] [Abstract][Full Text] [Related]
56. Choroidal effusion as a mechanism for transient myopia induced by hydrochlorothiazide and triamterene. Söylev MF; Green RL; Feldon SE Am J Ophthalmol; 1995 Sep; 120(3):395-7. PubMed ID: 7661215 [TBL] [Abstract][Full Text] [Related]
57. [A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension]. Bolzano K; Krempler F; Sandhofer F Acta Med Austriaca; 1984; 11(2):49-53. PubMed ID: 6377793 [TBL] [Abstract][Full Text] [Related]
58. Enalapril and enalapril-hydrochlorothiazide in the treatment of essential hypertension. The Enalapril-Hydrochlorothiazide in Essential Hypertension Canadian Working Group. Clin Ther; 1993; 15(2):364-73. PubMed ID: 8519044 [TBL] [Abstract][Full Text] [Related]
59. Influence of hypotensive drug treatment in elderly hypertensives: study terminating events in the trial of the European Working Party on High Blood Pressure in the Elderly. Amery A; Birkenhäger W; Brixko P; Bulpitt C; Clement D; de Leeuw P; De Plaen JF; Deruyttere M; De Schaepdryver A; Dollery C J Hypertens Suppl; 1985 Dec; 3(3):S501-11. PubMed ID: 2856778 [TBL] [Abstract][Full Text] [Related]
60. A study of plasma sodium levels in elderly people taking amiloride or triamterene in combination with hydrochlorothiazide. Fidler HM; Goldman J; Bielawska CA; Rai GS; Hoffbrand BI Postgrad Med J; 1993 Oct; 69(816):797-9. PubMed ID: 8290411 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]